{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:10Z","timestamp":1786628230246,"version":"build-2736575974"},"reference-count":102,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>Despite vulvar cancer\u2019s rarity, meaningful advances have been made to improve the clinical care of affected patients\u2014particularly with respect to vulvar squamous cell carcinoma (VSCC). These advances are reflected in changes to tumor classification, surgical strategies, early detection of precursors, and targeted therapeutic exploration. Refinements in histopathologic and molecular classification have enhanced diagnostic precision, enabling more accurate prognostication and facilitating personalized therapeutic decision-making, particularly tailored surgical strategies that can be explored through clinical trials\u2014to improve patient outcomes while reducing patient morbidity. Increased awareness of VSCC precursors have also opened avenues for earlier intervention. This review highlights the key changes in the evolution of VSCC care, with particular emphasis on the expanding responsibilities of pathologists in tumor subtyping [by human papillomavirus (HPV) and p53 status], biomarker-based prognostication, margin evaluation, recognition of precursors and alignment of precursor terminology (particularly HPV independent p53 wild-type lesions). By highlighting both progress and limitations, this review aims to inform future strategies that will further optimize patient outcomes and advance the standard of care in VSCC.<\/jats:p>","DOI":"10.1097\/pgp.0000000000001188","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:00:10Z","timestamp":1779757210000},"page":"383-394","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Vulvar Squamous Cell Carcinoma: Scientific Progress and Impacts to Pathology Practice"],"prefix":"10.1097","volume":"45","author":[{"given":"Lynn","family":"Hoang","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Division of Anatomical Pathology, Vancouver General Hospital and University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayah","family":"Alsolami","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Division of Anatomical Pathology, Vancouver General Hospital and University of British Columbia"},{"name":"Department of Pathology and Laboratory Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Gilks","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Division of Anatomical Pathology, Vancouver General Hospital and University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"McAlpine","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Jamieson","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"R1-20260813","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/jcm11041025","article-title":"Squamous cell carcinoma of the vulva: a survival and epidemiologic study with focus on surgery and radiotherapy","volume":"11","author":"Scampa","year":"2022","journal-title":"J Clin Med"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ygyno.2019.07.009","article-title":"Predicting the course of disease in recurrent vulvar cancer\u2014a subset analysis of the AGO-CaRE-1 study","volume":"154","author":"Woelber","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R5-20260813","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00404-020-05949-w","article-title":"A risk factor analysis of complications after surgery for vulvar cancer","volume":"304","author":"Gitas","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"R6-20260813","first-page":"1781","article-title":"Vulvar squamous cell carcinoma: a retrospective analysis of epidemiologic characteristics, HPV status, and surgical outcomes in 35 cases","volume":"15","author":"Marinescu","year":"2025","journal-title":"Life Basel Switz"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"qfac002","DOI":"10.1093\/sexmed\/qfac002","article-title":"A qualitative study of sexual health and function of females with pelvic cancer","volume":"11","author":"Oveisi","year":"2023","journal-title":"Sex Med"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000478-199302000-00005","article-title":"Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses","volume":"17","author":"Kurman","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00004347-199104000-00001","article-title":"Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction","volume":"10","author":"Toki","year":"1991","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/1097-0142(19910315)67:6<1599::AID-CNCR2820670622>3.0.CO;2-M","article-title":"Possible etiologic heterogeneity of vulvar intraepithelial neoplasia. A correlation of pathologic characteristics with human papillomavirus detection by in situ hybridization and polymerase chain reaction","volume":"67","author":"Park","year":"1991","journal-title":"Cancer"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/LGT.0000000000000182","article-title":"Biomarkers p16, human papillomavirus and p53 predict recurrence and survival in early stage squamous cell carcinoma of the vulva","volume":"20","author":"Hay","year":"2016","journal-title":"J Low Genit Tract Dis"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/his.13205","article-title":"Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study","volume":"71","author":"McAlpine","year":"2017","journal-title":"Histopathology"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/PAS.0000000000000454","article-title":"Squamous cell carcinoma of the vulva: a subclassification of 97 cases by clinicopathologic, immunohistochemical, and molecular features (p16, p53, and EGFR)","volume":"39","author":"Dong","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/PGP.0000000000000620","article-title":"HPV-independent vulvar squamous cell carcinoma is associated with significantly worse prognosis compared With HPV-associated tumors","volume":"39","author":"Allo","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20260813","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2018.03.003","article-title":"Vulvar cancer: two pathways with different localization and prognosis","volume":"149","author":"Hinten","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/ijgc-2022-003616","article-title":"HPV-independent and HPV-associated vulvar squamous cell carcinoma: two different cancers","volume":"32","author":"Eva","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/ijgc-2019-000793","article-title":"Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma","volume":"30","author":"Proctor","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2016.05.019","article-title":"Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy","volume":"142","author":"Lee","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.pas.0000213251.82940.bf","article-title":"p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas","volume":"30","author":"Santos","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R20-20260813","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ygyno.2003.11.052","article-title":"Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma","volume":"92","author":"Pinto","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R21-20260813","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ygyno.2011.05.016","article-title":"Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?","volume":"122","author":"Alonso","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R22-20260813","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jid.2021.10.009","article-title":"Human papillomavirus\u2013positive and \u2013negative vulvar squamous cell carcinoma are biologically but not clinically distinct","volume":"142","author":"Kolitz","year":"2022","journal-title":"J Invest Dermatol"},{"key":"R23-20260813","doi-asserted-by":"crossref","first-page":"3739075","DOI":"10.1155\/2020\/3739075","article-title":"The clinical relevance of p16 and p53 status in patients with squamous cell carcinoma of the vulva","volume":"2020","author":"Barlow","year":"2020","journal-title":"J Oncol"},{"key":"R24-20260813","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/gyno.1995.1152","article-title":"T2\/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy","volume":"57","author":"Siller","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R25-20260813","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(18)30109-8","article-title":"Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial","volume":"19","author":"H\u00f6ckel","year":"2018","journal-title":"Lancet Oncol"},{"key":"R26-20260813","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2010.06.019","article-title":"Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy","volume":"119","author":"H\u00f6ckel","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R27-20260813","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/ijgc-2021-003251","article-title":"Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique","volume":"32","author":"Thompson","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R28-20260813","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.31006","article-title":"Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: a study of 1,594 cases","volume":"141","author":"Rakislova","year":"2017","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"R32-20260813","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ijgo.70390","article-title":"Cancer of the vulva: 2025 update: FIGO cancer report 2025","volume":"171","author":"Olawaiye","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"R33-20260813","doi-asserted-by":"crossref","first-page":"117","DOI":"10.6004\/jnccn.2024.0013","article-title":"Vulvar cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Abu-Rustum","year":"2024","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"R34-20260813","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/aogs.14689","article-title":"TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma","volume":"103","author":"Dongre","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R35-20260813","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/his.14925","article-title":"Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features","volume":"83","author":"Carreras-Dieguez","year":"2023","journal-title":"Histopathology"},{"key":"R36-20260813","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/PGP.0000000000001077","article-title":"Role of immunohistochemical analysis of p16 and p53 in vulvar carcinoma","volume":"44","author":"Choschzick","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R37-20260813","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1158\/1078-0432.CCR-17-1302","article-title":"Genomic characterization of vulvar (Pre)cancers identifies distinct molecular subtypes with prognostic significance","volume":"23","author":"Nooij","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R38-20260813","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2020.09.024","article-title":"Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes","volume":"159","author":"Kortekaas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R39-20260813","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar cancer\u2014update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"R40-20260813","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejogrb.2023.11.013","article-title":"British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: an update on recommendations for practice 2023","volume":"292","author":"Morrison","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R41-20260813","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"R42-20260813","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod Pathol"},{"key":"R43-20260813","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/his.14109","article-title":"Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma","volume":"77","author":"Kortekaas","year":"2020","journal-title":"Histopathology"},{"key":"R44-20260813","doi-asserted-by":"crossref","first-page":"100574","DOI":"10.1016\/j.modpat.2024.100574","article-title":"Whole-exome sequencing of vulvar squamous cell carcinomas reveals an impaired prognosis in patients with TP53 mutations and concurrent CCND1 gains","volume":"37","author":"Ordi","year":"2024","journal-title":"Mod Pathol"},{"key":"R45-20260813","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PAS.0000000000002336","article-title":"Interpretation of p16 and p53 in the classification of squamous cell carcinoma of the vulva\u2014an interobserver agreement study","volume":"49","author":"Jeffus","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R46-20260813","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/his.15561","article-title":"Six-pattern p53 interpretation in 1293 vulvar squamous cell carcinomas: inter-pathologist variation and pattern distribution according to p16 status","volume":"87","author":"Kaderly Rasmussen","year":"2025","journal-title":"Histopathology"},{"key":"R47-20260813","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/PGP.0000000000001111","article-title":"Proficiency testing of p53 immunohistochemistry pattern read-out in vulvar biopsies demonstrates frequent basal overexpression interpretation in TP53 wild-type cases","volume":"44","author":"Wei","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R48-20260813","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.modpat.2023.100145","article-title":"Classification of vulvar squamous cell carcinoma and precursor lesions by p16 and p53 immunohistochemistry: considerations, caveats, and an algorithmic approach","volume":"36","author":"Yang","year":"2023","journal-title":"Mod Pathol"},{"key":"R49-20260813","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2024.02.001","article-title":"High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining","volume":"185","author":"H\u00f6hn","year":"2024","journal-title":"Gynecol Oncol"},{"key":"R50-20260813","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0000000000001047","article-title":"Confusing histopathological features and HPV testing results in vulvar squamous cell carcinoma arising in a young woman: a case solved using next-generation sequencing","volume":"44","author":"Sisuashvili","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R51-20260813","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/v15091950","article-title":"Betapapillomaviruses in p16-negative vulvar intraepithelial lesions associated with squamous cell carcinoma","volume":"15","author":"Lozar","year":"2023","journal-title":"Viruses"},{"key":"R52-20260813","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/PAS.0000000000002367","article-title":"Clinicopathologic features and viral status of low-risk HPV6 and HPV11-associated squamous cell carcinoma of the uterine cervix and vulva","volume":"49","author":"Williams","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R53-20260813","doi-asserted-by":"crossref","first-page":"121","DOI":"10.6004\/jnccn.2017.0009","article-title":"Surgical management of vulvar cancer","volume":"15","author":"Dellinger","year":"2017","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"Suppl 2","key":"R54-20260813","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ijgo.12609","article-title":"Cancer of the vulva","volume":"143","author":"Rogers","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"R55-20260813","first-page":"89","article-title":"No. 370-management of squamous cell cancer of the vulva","volume":"41","author":"Francis","year":"2019","journal-title":"J Obstet Gynaeco"},{"key":"R56-20260813","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-R","article-title":"Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva","volume":"38","author":"Heaps","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R57-20260813","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/cncr.10969","article-title":"Vulvar carcinoma. The price of less radical surgery","volume":"95","author":"De Hullu","year":"2002","journal-title":"Cancer"},{"key":"R58-20260813","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2006.10.004","article-title":"Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis","volume":"104","author":"Chan","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R59-20260813","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3390\/cancers12113375","article-title":"The prognostic role of the surgical margins in squamous vulvar cancer: a retrospective Australian study","volume":"12","author":"Barlow","year":"2020","journal-title":"Cancers"},{"key":"R60-20260813","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1111\/jog.14962","article-title":"Positive surgical margin is an independent predictor of overall survival of patients with vulvar squamous cell carcinoma","volume":"47","author":"Nomura","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"R61-20260813","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2016.07.006","article-title":"Tumour-free margins in vulvar squamous cell carcinoma: does distance really matter?","volume":"65","author":"Nooij","year":"2016","journal-title":"Eur J Cancer"},{"key":"R62-20260813","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-011-1778-0","article-title":"Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva","volume":"18","author":"Woelber","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R63-20260813","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ejso.2018.05.031","article-title":"Surgical margins in squamous cell carcinoma, different for the vulva?","volume":"44","author":"Pleunis","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"R64-20260813","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00404-025-08046-y","article-title":"Influence of resection distance on vulvar cancer relapse: a retrospective analysis","volume":"312","author":"Cieslik","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"R65-20260813","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.3390\/jcm14124057","article-title":"Impact of surgical margin distance on oncologic outcomes in vulvar squamous cell carcinoma","volume":"14","author":"Lenz","year":"2025","journal-title":"J Clin Med"},{"key":"R66-20260813","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/IGC.0000000000001195","article-title":"The role of pathological margin distance and prognostic factors after primary surgery in squamous cell carcinoma of the vulva","volume":"28","author":"Arvas","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"R67-20260813","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ejso.2019.07.005","article-title":"Surgical treatment of vulvar cancer: impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the FRANCOGYN study group","volume":"45","author":"Raimond","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R68-20260813","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.3802\/jgo.2026.37.e26","article-title":"Association between resection margin and local recurrence in the treatment of primary squamous cell vulvar carcinoma","volume":"37","author":"Hanna","year":"2026","journal-title":"J Gynecol Oncol"},{"key":"R69-20260813","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","article-title":"Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie CaRE-1 multicenter study","volume":"69","author":"Woelber","year":"2016","journal-title":"Eur J Cancer"},{"key":"R70-20260813","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2017.11.006","article-title":"Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: a systematic review","volume":"148","author":"Te Grootenhuis","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R71-20260813","doi-asserted-by":"crossref","first-page":"796","DOI":"10.5603\/gpl.98720","article-title":"Vulval squamous cell cancer\u2014does precursor lesion margin status affect recurrence-free survival after optimal surgical resection for early-stage disease?","volume":"95","author":"Durden","year":"2024","journal-title":"Ginekol Pol"},{"key":"R72-20260813","first-page":"397","article-title":"Vulval squamous cell carcinoma occurring on a background of differentiated vulval intraepithelial neoplasia is more likely to recur: a review of 154 cases","volume":"53","author":"Eva","year":"2008","journal-title":"J Reprod Med"},{"key":"R73-20260813","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.06.019","article-title":"Adjacent lichen sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma","volume":"142","author":"Yap","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R74-20260813","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2025.03.049","article-title":"Trop2-expression in primary vulvar squamous cell carcinoma","volume":"196","author":"Stuebs","year":"2025","journal-title":"Gynecol Oncol"},{"key":"R75-20260813","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.modpat.2022.100010","article-title":"p53-Abnormal \u201cFields of Dysplasia\u201d in human papillomavirus-independent vulvar squamous cell carcinoma impacts margins and recurrence risk","volume":"36","author":"Thompson","year":"2023","journal-title":"Mod Pathol"},{"key":"R76-20260813","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/PAS.0000000000000291","article-title":"Expanding the morphologic spectrum of differentiated VIN (dVIN) through detailed mapping of cases with p53 loss","volume":"39","author":"Singh","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R77-20260813","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/ijgc-2022-003763","article-title":"Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma","volume":"32","author":"Thompson","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R78-20260813","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/aogs.14814","article-title":"Differentiated vulvar intraepithelial neoplasia long-term follow up and prognostic factors: an analysis of a large historical cohort","volume":"103","author":"Gallio","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R79-20260813","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/his.15050","article-title":"High-grade vulvar intraepithelial neoplasia: comprehensive characterization and long-term vulvar carcinoma risk","volume":"84","author":"Thuijs","year":"2024","journal-title":"Histopathology"},{"key":"R80-20260813","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.3390\/cancers13246170","article-title":"The vulvar cancer risk in differentiated vulvar intraepithelial neoplasia: a systematic review","volume":"13","author":"Voss","year":"2021","journal-title":"Cancers"},{"key":"R81-20260813","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.33198","article-title":"Vulvar intraepithelial neoplasia: incidence and long-term risk of vulvar squamous cell carcinoma","volume":"148","author":"Thuijs","year":"2021","journal-title":"Int J Cancer"},{"key":"R82-20260813","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/PGP.0000000000000280","article-title":"The natural history of vulvar intraepithelial neoplasia, differentiated type: evidence for progression and diagnostic challenges","volume":"35","author":"Bigby","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R83-20260813","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PGP.0000000000000375","article-title":"HPV-independent differentiated vulvar intraepithelial neoplasia (dVIN) is associated with an aggressive clinical course","volume":"36","author":"McAlpine","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R84-20260813","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1097\/PAS.0000000000001540","article-title":"HPV-independent precursors mimicking high-grade squamous intraepithelial lesions (HSIL) of the vulva","volume":"44","author":"Rakislova","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R85-20260813","doi-asserted-by":"crossref","first-page":"TPS5637","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS5637","article-title":"Stratification of vulvar squamous cell carcinoma (VSCC) by HPV and P53 status to guide excision: CCTG VU.2 STRIVE study (NCT06358469)","volume":"43","author":"Jamieson","year":"2025","journal-title":"J Clin Oncol"},{"key":"R86-20260813","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/modpathol.2016.187","article-title":"Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA","volume":"30","author":"Watkins","year":"2017","journal-title":"Mod Pathol"},{"key":"R87-20260813","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/00000478-200405000-00012","article-title":"Vulvar acanthosis with altered differentiation: a precursor to verrucous carcinoma?","volume":"28","author":"Nascimento","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R88-20260813","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/LGT.0000000000000569","article-title":"Clinicopathologic diagnosis of differentiated vulvar intraepithelial neoplasia and vulvar aberrant maturation","volume":"24","author":"Day","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R89-20260813","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/LGT.0000000000000572","article-title":"Diagnostic criteria for differentiated vulvar intraepithelial neoplasia and vulvar aberrant maturation","volume":"25","author":"Heller","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"R90-20260813","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/s41379-022-01168-7","article-title":"Comment on HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize acanthotic precursor lesions of the vulva. Parra-Herran C. et al Mod Pathol 2022 Apr 18 doi: 10.1038\/s41379-022-01079-7","volume":"35","author":"Bohl","year":"2022","journal-title":"Mod Pathol"},{"key":"R91-20260813","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41379-022-01079-7","article-title":"HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva","volume":"35","author":"Parra-Herran","year":"2022","journal-title":"Mod Pathol"},{"key":"R92-20260813","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/s41379-020-0573-5","article-title":"Differentiated exophytic vulvar intraepithelial lesion: clinicopathologic and molecular analysis documenting its relationship with verrucous carcinoma of the vulva","volume":"33","author":"Akbari","year":"2020","journal-title":"Mod Pathol"},{"key":"R93-20260813","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/PGP.0000000000001094","article-title":"Verruciform acanthotic vulvar intraepithelial neoplasia harbors recurrent genomic alterations found in HPV-independent squamous cell carcinoma","volume":"44","author":"Cook","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R94-20260813","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/his.14451","article-title":"DEVIL, VAAD and vLSC constitute a spectrum of HPV-independent, p53-independent intra-epithelial neoplasia of the vulva","volume":"79","author":"Roy","year":"2021","journal-title":"Histopathology"},{"key":"R95-20260813","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41379-020-00651-3","article-title":"Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome","volume":"34","author":"Tessier-Cloutier","year":"2021","journal-title":"Mod Pathol"},{"key":"R96-20260813","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/his.14442","article-title":"Interobserver reproducibility of the diagnosis of differentiated exophytic vulvar intraepithelial lesion (DEVIL) and the distinction from its mimics","volume":"79","author":"Neville","year":"2021","journal-title":"Histopathology"},{"key":"R97-20260813","doi-asserted-by":"crossref","first-page":"100900","DOI":"10.1016\/j.modpat.2025.100900","article-title":"GLUT1 Expression patterns in verruciform acanthotic vulvar squamous intraepithelial neoplasia, HPV-independent p53 wild-type squamous cell carcinoma and benign vulvar lesions","volume":"38","author":"Zhang","year":"2025","journal-title":"Mod Pathol"},{"key":"R98-20260813","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/PAS.0000000000002383","article-title":"CK17 Immunohistochemistry is a useful adjunct in the diagnosis of HPV-independent, TP53-wild-type verruciform\/acanthotic vulvar intraepithelial neoplasia (vaVIN)","volume":"49","author":"Hartsough","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R99-20260813","first-page":"324","article-title":"Evaluation of immunohistochemical markers, CK17 and SOX2, as adjuncts to p53 for the diagnosis of differentiated vulvar intraepithelial neoplasia (dVIN)","volume":"14","author":"Dasgupta","year":"2021","journal-title":"Pharm Basel Switz"},{"key":"R100-20260813","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/his.14238","article-title":"Comparison of p53 immunohistochemical staining in differentiated vulvar intraepithelial neoplasia (dVIN) with that in inflammatory dermatoses and benign squamous lesions in the vulva","volume":"78","author":"Liu","year":"2021","journal-title":"Histopathology"},{"key":"R101-20260813","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/his.15112","article-title":"PD-L1 expression in vulvar cancer: a systematic review and meta-analysis","volume":"84","author":"Baandrup","year":"2024","journal-title":"Histopathology"},{"key":"R102-20260813","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2022.01.029","article-title":"Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: results from the phase 2 KEYNOTE-158 study","volume":"166","author":"Shapira-Frommer","year":"2022","journal-title":"Gynecol Oncol"},{"key":"R103-20260813","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.19.00739","article-title":"Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I\/II CheckMate 358 trial","volume":"37","author":"Naumann","year":"2019","journal-title":"J Clin Oncol"},{"key":"R104-20260813","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2025.11.009","article-title":"Exploring novel therapeutic targets in vulvar squamous cell carcinoma","volume":"204","author":"Rhind","year":"2026","journal-title":"Gynecol Oncol"},{"key":"R105-20260813","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1007\/s00432-023-04761-8","article-title":"TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target","volume":"149","author":"Condic","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R106-20260813","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000543554","article-title":"Trop2 expression in correlation to the molecular subtype in vulvar squamous cell carcinomas","volume":"92","author":"H\u00f6hn","year":"2025","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:01:41Z","timestamp":1786626101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001188","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2026-02-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}